NICE and new drugs for rheumatoid arthritis.
D000069594:Abatacept; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000191:economics / Q000627:therapeutic use*; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence*; D019057:Quality-Adjusted Life Years; D006113:United Kingdom
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D000069594:Abatacept